SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
272 hedge funds and large institutions have $10.6B invested in Sage Therapeutics in 2019 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 99 increasing their positions, 83 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 267 → 272 (+5)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
36% less call options, than puts
Call options by funds: $103M | Put options by funds: $162M
Holders
272
Holding in Top 10
7
Calls
$103M
Puts
$162M
Top Buyers
| 1 | +$575M | |
| 2 | +$246M | |
| 3 | +$239M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$114M |
| 5 |
Jennison Associates
New York
|
+$110M |
Top Sellers
| 1 | -$75.8M | |
| 2 | -$75M | |
| 3 | -$61.1M | |
| 4 |
Bank of New York Mellon
New York
|
-$49.5M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$27M |